Synex Medical just raised $21.8 million to build a portable MRI capable of testing glucose and other important molecules ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...

Shares of DexCom Inc. DXCM slid 2.07% to $70.43 Friday, on what proved to be an all-around mixed trading session for the ...

Nearly 40 million Americans have diabetes, and nearly half of those are people who have Type 2 diabetes and are aged 65 or older. This population has a higher risk of ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company's ...

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...

New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) on September 13 and set a price target of ...